Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 14, 2014; 20(26): 8482-8490
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8482
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8482
Ref. | Method | Grading | Reference cells | Groups (n) |
Spratlin et al[9] | IHC | 0-2 based on relative intensities of staining. | Langerhans cells, lymphocytes. | Dichotomized: |
0 = absence of staining | Low = 0 (12) | |||
1 = intermediate staining | High = 1 and 2 (9) | |||
2 = most intense staining | ||||
Giovannetti et al[10] | RT-PCR | Gene-expression ratio with GAPDH, expressed as tertiles | Gene expression tertiles: | |
GAPDH/target gene ratio | Low < 1.06 (27) | |||
Intermediate 1.06-1.38 (28) | ||||
High ≥ 1.38 (26) | ||||
Dichotomized: | ||||
By medians | ||||
Low < 1.23 (44) | ||||
High ≥ 1.23 (37) | ||||
Farrell et al[12] | IHC | Based on relative intensities. | Lymphocytes | Dichotomized: |
High = strong reactivity in > 50% of neoplastic cells. | No (18)1 | |||
No = no staining in > 50% | vs | |||
Low = all cases between High and No. | Low/high (73)1 | |||
Maréchal et al[3] | IHC | 0-3 based on staining intensities | Langerhans cells | Dichotomized: |
0 = no staining | Lymphocytes | Low < 80 (26) | ||
1 = weakly positive | (final score) | |||
2 = moderately positive | ||||
3 = strongly positive | High = ≥ 80 (19) | |||
Final score calculated: multiplying intensity score and the percentage of the specimen. Weighted score 0-300 | ||||
Fujita et al[8] | RT-PCR | Level of mRNA calculated from standard curve constructed with total RNA from Capan-1, a human pancreatic cancer cell line | mRNA split into high/low groups using recursive descent partitioning. Cut-off 0.5 | |
Low (26)1 | ||||
High (14) | ||||
Maréchal et al[1] | IHC | 0-2 based on staining intensities | Lymphocytes | Dichotomized: |
Quantified as Farrell | Low/moderate (136)1 | |||
High (86)1 | ||||
Kawada et al[2] | IHC | 0-2 based on staining intensities. | Langerhans cells | Negative = 0-1 (41) |
1 = same intensity as control. | Positive = 2 (22) | |||
Morinaga et al[21] | IHC | Staining intensity and percentage of positive tumor cells scored and given a hENT1-score by calculating the two | Low = hENT1 score 0-3 (11) | |
Staining 0-3 where | High = hENT1 score 4-6 (16) | |||
0 = no | ||||
1= weakly pos | ||||
2 = moderately pos | ||||
3 = strongly pos | ||||
Percentage: | ||||
0 = no positive | ||||
1 ≤ 50% positive cells | ||||
2 = 50%-80% positive cells | ||||
3 = ≥ 80% | ||||
Murata et al[22] | IHC | Staining intensity + extent of positive staining | Langerhans cells | Dichotomized: |
Intensity: | Negative = low and intermediate (16) | |||
0 = no staining | ||||
1 = weakly positive | Positive = high (39) | |||
2 = moderately positive | ||||
3 = strongly positive | ||||
Extent staining: | ||||
High = score 3 > 50% cells | ||||
Low = score 0 or 1 > 50% | ||||
Intermediate = all others | ||||
Nakagawa et al[23] | IHC | Staining intensities: | Langerhans cells | Low = grade 0 or 1 in > 50% (31) |
0 = not stained | High = grade 2 or 3 in > 50% of cells (78) | |||
1 = faintly stained | ||||
2 = weakly stained | ||||
3 = as strongly as islet cells |
- Citation: Nordh S, Ansari D, Andersson R. hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review. World J Gastroenterol 2014; 20(26): 8482-8490
- URL: https://www.wjgnet.com/1007-9327/full/v20/i26/8482.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i26.8482